American Medical Systems Holdings Inc. announced unaudited consolidated earnings results for the third quarter and nine months ended October 3, 2009. For the quarter, the company reported revenue of $123.2 million, a 4.9% increase from revenue of $117.5 million in the comparable quarter of 2008. Excluding the impact of foreign currency fluctuations, third quarter revenue grew 6.7% over the same period last year. On a GAAP basis, the company reported 2009 third quarter net income of $28.6 million, or $0.38 diluted per share, compared to net income in the same period last year of $3.5 million, or $0.05 diluted per share. The company also reported very strong non-GAAP adjusted net income of $20 million or $0.27 diluted per share for the third quarter of 2009 compared to adjusted net income of $13.7 million or $0.18 diluted per share in the comparable period last year. The company reported operating income of $33.21 million and income before income taxes of $47.8 million compared to operating income of $17.5 million and income before income taxes of $6.4 million for the same period last year. For the nine months. The company reported net income of $62.6 million or $0.84 diluted per share on the net sales of $373.3 million compared to net income of $21.4 million or $0.29 diluted per share on the net sales of $367.63 million for the same period last year. The company reported operating income of $97 million and income before income taxes of $101 million compared to operating income of $66.14 million and income before income taxes of $36.2 million for the same period last year. The company reported net cash provided by operating activities of $97.18 million and purchase of property, plant and equipment of $3.7 million compared to net cash provided by operating activities of $78.63 million and purchase of property, plant and equipment of $4.14 million for the same period last year. The company reported non-GAAP adjusted net income of $60.3 million or $0.81 diluted per share compared to non-GAAP adjusted net income of $42.4 million or $0.57 diluted per share for the same period last year. The company estimates fourth quarter revenue in the range of $136 to $142 million. Reflecting the strong earnings performance experienced in the first three quarters of 2009, the company estimates fourth quarter 2009 non-GAAP adjusted earnings per share will be in the range of $0.29 to $0.33. For the full year, the company expected revenue guidance of $509 to $515 million, an increase from previous 2009 revenue guidance of $495 to $510 million. This guidance assumes foreign currency exchange rates remain constant with current rates. The company estimates that the adoption of this new accounting guidance will reduce net income for fiscal year 2009 by approximately $0.11 per share. The company estimates full year 2009 non-GAAP adjusted earnings per share in the range of $1.10 to $1.14. This is an increase from previous guidance for the full year 2009 in the range of $1.00 to $1.10.

American Medical Systems Holdings Inc. announced cash flow results for the third quarter of 2009. For the quarter, the company generated $37.3 million in cash from operations as a result of a previously mentioned margin improvements as well as solid working capital management.

American Medical Systems Holdings Inc. announced that it has received clearance from the Japanese Ministry of Health, Labor and Welfare (MHLW) to market and distribute its AMS 800 Artificial Urinary Sphincter (AUS) in Japan, effective September 7, 2009. The AMS 800 is a medical device which is implanted and completely concealed inside the patient's body. The device effectively controls the flow of urine and restores continence. This first-of-its-kind product in Japan offers incontinent patients an alternative to traditional pad and diaper therapy.